Cellmid 2018 Annual Report
NOTES TO THE
8. EARNINGS PER SHARE
Basic earnings per share
Basic earnings per share is calculated by dividing the proﬁt or loss attributable to owners of Cellmid Limited, excluding any
costs of servicing equity other than ordinary shares, by the weighted average number of ordinary shares outstanding during the
ﬁnancial year, adjusted for bonus elements in ordinary shares issued during the ﬁnancial year.
Diluted earnings per share
Diluted earnings per share adjusts the ﬁgures used in the determination of basic earnings per share to take into account the
after income tax effect of interest and other ﬁnancing costs associated with dilutive potential ordinary shares and the weighted
average number of shares assumed to have been issued for no consideration in relation to dilutive potential ordinary shares.
Details relating to options are set out in Note 18.
9. CASH AND CASH EQUIVALENTS
Cash and cash equivalents include cash on hand, deposits available on demand with banks, other short-term highly
liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are reported within
short-term borrowings in current liabilities in the consolidated statement of ﬁnancial position.
Basic and diluted earnings per share (in cents) (6.74) (8.79)
Reconciliation of earnings to proﬁt or loss from continuing operations
Loss for the year attributable to the owners of Cellmid Limited (3,732,615) (4,482,273)
Weighted average number of ordinary shares used in calculating basic No. No.
and dilutive earnings per share 55,355,156 51,007,948
Cash at bank and on hand 1,607,783 3,994,641
The effective interest rate on short term bank deposits at 30 June 2018 was 1.20% (2017: 1.75%); these deposits were all at call.
Reconciliation of cash
Cash and cash equivalents reported in the statement of cash ﬂows are reconciled to the equivalent items in the statement of
ﬁnancial position as follows:
Cash and cash equivalents 1,607,783 3,994,641